All Type of News
90% of asbestos contaminated medicines are discarded, KFDA says
The Korea Food and Drug Administration says the majority of 122 drugs and medical goods confirmed to have used talc contaminated with asbestos were destroyed, while remaining items will be handled by a divided method....
Daewoong to build 250 billion won plant
Daewoong Pharm says it will invest 250 billion won to build a current Good Manufacturing Practice plant in Chungju by 2013.
To make inroad into overseas markets, we will build a new plant,’’ a company official said...
Boryung to build GMP plant in 2011
Boryung Pharm is planning to build its plant at a complex to be created at Yesan of South Chooncheon Province in 2011.
Boryung officials said the plant will give an industrial edge to the whole Boryung affliliates....
Leading toothbrush brand to go on sale
Dong-A Pharm will join the local toothbrush market with an exclusive marketing right of Jordan, No. 1 brand in the Northern Europe.
The company is expected to generate a bigger sale with the renowned brand in the y...
Ildong to release hyaluronic acid as finished form
Ildong Pharm is in a final stage to develop hyaluronic acid, company official said.
The company is set to produce the finished products by 2011 in Chunju plant and seek to boost the sales in the overseas market.
...
Wyeth urged to mend fences with Daewoong
Wyeth Pharmaceuticals will have to seek a win-win game with Daewoong Pharm as their relations have turned sour since the stern refusal of Wyeth over the development of novel anti-infective agent, according to market o...
Boryung wins patent nullification trial over Arimidex
The local patent trial board has recently ruled against AstraZeneca’s Arimidex (anastrozole) patent in its nullification trial which has been sought by Boryung Pharm.
Anastrozole is a drug used to treat breast canc...
Wholesalers seeking to correct unfair contract terms with Zuellig
Pharmaceutical wholesalers in Seoul have rolled up their sleeves to revise the unfair contract clauses with Zuellig Pharma Korea.
They said the current ZPK contract has contained many unfair clauses against the cur...
Safety concerns growing over adjuvanted vaccines
As concern over the safety of flu vaccines increases, a lawmaker feel a local drug company is putting profit above public safety, according to a lawmaker.
Currently, Korean drug-maker Green Cross Corp. has produced...
Price cut sparks Levitra shortage
The significant price reduction of Levitra (vardenafil) 10 mg, an erectile dysfunction medicine, is becoming an increasing boon for Bayer Healthcare Korea ― so much so that they're having trouble keeping up with deman...
